GNE-3511
Product Specifications
UNSPSC Description
GNE-3511 is an orally active bioavailable and brain-penetrant dual leucine zipper kinase (DLK) inhibitor with a Ki of 0.5 nM. GNE-3511 can cross the blood-brain-barrier and can be used for the research of neurodegenerative diseases[1].
Target Antigen
MAP3K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/GNE-3511.html
Purity
99.54
Solubility
DMSO : 31.25 mg/mL (ultrasonic)
Smiles
N#CC1=CC=NC(NC2=NC(N3CC(F)(F)CC3)=CC(C4CCN(C5COC5)CC4)=C2)=C1
Molecular Weight
440.49
References & Citations
[1]Patel S et al. Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models. J Med Chem. 2015 Jan 8;58(1):401-18.|[2]Chen Jiang, et al. Neuronal Dual Leucine Zipper Kinase Mediates Inflammatory and Nociceptive Responses in Cyclophosphamide-Induced Cystitis. J Innate Immun
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-12947/GNE-3511-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-12947/GNE-3511-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1496581-76-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E11C1846-01 48 Well
Bovine Cyclic nucleotide gated cation channel Alpha 3 (CNGA3) ELISA Kit
Ask
View Details 
E11C1846-02 96 Well
Bovine Cyclic nucleotide gated cation channel Alpha 3 (CNGA3) ELISA Kit
Ask
View Details 
